共 42 条
- [21] Efficacy and Safety of Inclisiran in Patients with Polyvascular Disease: Pooled, Post Hoc Analysis of the ORION-9, ORION-10, and ORION-11 Phase 3 Randomized Controlled TrialsCardiovascular Drugs and Therapy, 2024, 38 : 493 - 503Wolfgang KoenigLorena Garcia CondeUlf LandmesserLawrence A. LeiterKausik K. RayGregory G. SchwartzR Scott WrightJackie HanFrederick J. Raal
- [22] Efficacy, safety and tolerability of a halobetasol 0.01%/tazarotene 0.045% fixed combination in the treatment of severe plaque psoriasis: Post hoc analysis of 2 phase III randomized controlled trialsJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB202 - AB202Lebwohl, Mark G.Sugarman, Jeffrey L.Gold, Linda SteinLin, TinaHarris, SusanDesai, Chakshu
- [23] Effects of memantine on cognition in patients with moderate to severe Alzheimer's disease: post-hoc analyses of ADAS-cog and SIB total and single-item scores from six randomized, double-blind, placebo-controlled studiesINTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2009, 24 (05) : 532 - 538Mecocci, PatriziaBladstroem, AnnaStender, Karina
- [24] Efficacy of risankizumab across subgroups in patients with active psoriatic arthritis: a post hoc integrated analysis of the phase 3 KEEPsAKE 1 and KEEPsAKE 2 randomized controlled trialsJOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)Merola, Joseph F.Armstrong, AprilKhattri, SaakshiPaek, So YeonPadilla, ByronYue, CuiyongPhotowala, HuzefaKaplan, BlairKristensen, Lars Erik
- [25] Characterization of acne associated with upadacitinib treatment in patients with moderate-to-severe atopic dermatitis: A post hoc integrated analysis of 3 phase 3 randomized, double-blind, placebo-controlled trialsJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (04) : 784 - 791Mendes-Bastos, PedroLadizinski, BarryGuttman-Yassky, EmmaJiang, PingLiu, JohnPrajapati, Vimal H.Simpson, Eric L.Vigna, NamitaTeixeira, Henrique D.Barbarot, Sebastien
- [26] Efficacy and Safety of Duloxetine in Patients with Chronic Low Back Pain Who Used versus Did Not Use Concomitant Nonsteroidal Anti-Inflammatory Drugs or Acetaminophen: A Post Hoc Pooled Analysis of 2 Randomized, Placebo-Controlled TrialsPAIN RESEARCH AND TREATMENT, 2012, 2012Skljarevski, VladimirLiu, PengZhang, ShuyuAhl, JonnaMartinez, James M.
- [27] Effect of patient characteristics on the efficacy and safety of imeglimin monotherapy in Japanese patients with type 2 diabetes mellitus: A post-hoc analysis of two randomized, placebo-controlled trialsJOURNAL OF DIABETES INVESTIGATION, 2023, 14 (09) : 1101 - 1109Hagi, KatsuhikoKochi, KenjiWatada, HirotakaKaku, KoheiUeki, Kohjiro
- [28] Lasmiditan for acute treatment of migraine in patients with cardiovascular risk factors: post-hoc analysis of pooled results from 2 randomized, double-blind, placebo-controlled, phase 3 trialsJOURNAL OF HEADACHE AND PAIN, 2019, 20 (01):Shapiro, Robert E.Hochstetler, Helen M.Dennehy, Ellen B.Khanna, RashnaDoty, Erin GautierBerg, Paul H.Starling, Amaal J.
- [29] Lasmiditan for acute treatment of migraine in patients with cardiovascular risk factors: post-hoc analysis of pooled results from 2 randomized, double-blind, placebo-controlled, phase 3 trialsThe Journal of Headache and Pain, 2019, 20Robert E. ShapiroHelen M. HochstetlerEllen B. DennehyRashna KhannaErin Gautier DotyPaul H. BergAmaal J. Starling
- [30] Impact of patient and treatment characteristics on glycemic control and hypoglycemia in patients with type 2 diabetes initiated to insulin glargine or NPH A post hoc, pooled, patient-level analysis of 6 randomized controlled trialsMEDICINE, 2017, 96 (05)Porcellati, FrancescaLin, JayLucidi, PaolaBolli, Geremia B.Fanelli, Carmine G.